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INTRODUCTION
Although Moll et al. suggested that Beh et's disease (BD)
could be included in the spondyloarthropathy (SpA) complex
in 1974 (1), it is still debatable whether BD is one of this
disease complex. To date, the following evidences may sup-
port this hypothesis. First, some investigators have reported
an increased prevalence of sacroiliitis (SI) in patients with BD.
Second, several cases that simultaneously satisfied the classi-
fication criteria for BD and ankylosing spondylitis (AS) or
SpA have been reported. Third, there is a clinical overlap be-
tween BD and some diseases of the SpA complex such as in-
flammatory bowel disease and Reiter's syndrome.
The frequency of SI and AS in patients with BD has been
variably described according to investigators and countries
studied. Yazici et al. claimed that the high prevalence of SI
in BD might be due to a high observer variation in interpret-
ing the film of anteroposterior (AP) view of the pelvis, or the
studies which used no controls or were not performed in a
blinded pattern (2). In addition, Olivieri et al. pointed out
that the different origin of the series of BD and the different
diagnostic criteria used for diagnosing BD before the Interna-
tional Study Group (ISG) criteria might be another causes
of these discrepancies (3). On the other hand, they described
4 patients with SI among 20 patients with BD by using com-
puted tomography (4).
Up to date, the studies for this issue have been mainly lim-
ited to whether the prevalence of SI or AS is greater in patients
with BD. Therefore, we performed a study to compare the
characteristic clinical features and known susceptible HLA
antigens such as HLA-B27 and HLA-B51 in patients with
BD or SpA, to clarify whether BD could be classified into the
SpA complex. In addition, patients who concurrently satis-
fied the classification criteria of BD and SpA were reviewed.
MATERIALS AND METHODS
This study was prospectively undertaken on 58 patients
with BD (20 males and 38 females) (BD group) who satisfied
the ISG criteria (5), 56 patients with SpA (39 males and 17
females) (SpA group) who fulfilled the criteria by the Euro-
pean Spondyloarthropathy Study Group (ESSG) (6), 3 male
patients who concurrently satisfied the criteria of ISG and
ESSG (BDSpA group). The patients in these three disease
groups have been followed up from March 1999 to March
2001. The mean follow-up periods (±SD) of BD group and
SpA group were 14.6 months (±8.9) and 15.3 months (±
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The Comparison Between Behcet's Disease and Spondyloarthritides:
Does Behcet's Disease Belong to the Spondyloarthropathy Complex?
This study was to clarify whether Beh et's disease (BD) could be classified into the
spondyloarthropathy (SpA) complex. It was undertaken on 58 patients with BD (BD
group), 56 patients with SpA (SpA group), and 3 patients who concurrently satis-
fied the criteria for BD and SpA (BDSpA group). The clinical parameters and known
susceptible HLA antigens were compared between BD group and SpA group. In
addition, 3 patients in BDSpA group were reviewed. The prevalence of definitive
sacroiliitis (SI) in BD group and SpA group was 46.4% and 5.2%, respectively. How-
ever, none had a definitive SI in healthy controls. Enthesitis was observed in 3.4%
of BD group and in 50% of SpA group. The patterns of eye involvement were dif-
ferent between these two groups. HLA-B27 was negative in all 49 patients of BD
group, whereas it was positive in 67.9% of SpA group. The prevalence of HLA-B51
was 51.7% in BD group, and that in SpA group was 21.4%. One patient in BDSpA
group was considered to have concurrent BD and ankylosing spondylitis (AS). An-
other patient was closer to AS, and the third to BD. Conclusively, it seems that BD
could not be classified into the SpA complex.  
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,8.3), respectively. The SpA group consisted of 28 patients
with AS, 22 undifferentiated SpA, 3 psoriatic arthritis, 2 reac-
tive arthritis, and 1 enteropathic arthritis. The healthy con-
trols were composed of 56 healthy individuals (21 males and
35 females) who had visited for a medical checkup. The mean
ages (±SD) of patients in BD group and SpA group were
41.6 yr (±10.2) and 31.8 yr (±10.2), respectively. The mean
age of the healthy controls was 42.7 yr (±10.0).
AP pelvis radiographs were obtained from all individuals
after informed consent. Two radiologists and one rheumatol-
ogist read the radiographs in a random manner by the grad-
ing system of SI according to the New York criteria (7) with-
out clinical information. It was considered to have SI when
2 investigators interpreted as over grade 2 in each individu-
al. In addition, patients were considered to have a definitive
SI when 2 investigators interpreted as over grade 3 or all 3
investigators read as over grade 2. 
Enthesitis was documented as past or present pain or ten-
derness on examination of the insertion of the Achilles ten-
don or plantar fascia, present pain and tenderness at the iliac
crests, greater trochanters, ischial tuberosities, and tibial tu-
berosities (6, 8). All individuals in three disease groups were
examined and educated for an ocular manifestation by the
same ophthalmologist at the initial visit and whenever the
ocular manifestations occurred. 
The test for HLA-B27 antigen was performed using micro-
lymphocytotoxicity method in 49 patients of BD group, in
all patients of SpA group or BDSpA group. HLA-B51 was
tested by the two-step polymerase chain reaction with se-
quence-specific primers method in all patients (9, 10). Sta-
tistical analysis was done by Fisher's exact test. The p-values
less than 0.05 were considered to be statistically significant.
In addition, three patients in BDSpA group were reviewed.
RESULTS
SI was found in 58.9% of SpA group, in 10.3% of BD
group, and in 3.6% of healthy controls. The prevalence of
SI in BD group was significantly lower than that in SpA
group (p<0.001), and although it was slightly higher than
in healthy controls, there was no statistically significant dif-
ference between these two groups (p=0.272). In addition, the
definitive SI was observed in 46.4% of SpA group and in
5.2% of BD group. However, none had the definitive SI in
healthy controls, and there was no statistically significant
difference in frequencies of definitive SI between BD group
and healthy controls (Table 1).
The enthesitis was found in 2 patients of BD group (3.4%)
and in 28 patients of SpA group (50%) (p<0.001). The ocu-
lar involvement was found in 12 patients (20.7%) of BD
group in the following patterns: 7 patients with anterior and
posterior uveitis (12.1%), 2 patients with posterior uveitis
and retinal vasculitis (3.4%), 2 patients with anterior uveitis
(3.4%), and 1 patient with scleritis (1.7%). However, all ten
patients with the ocular involvement in SpA group (17.9%)
had anterior uveitis.
HLA-B27 was negative in all 49 patients of BD group, and
it was positive in 38 patients of SpA group (67.9%). The
prevalence of HLA-B51 in BD group was 51.7% and that
in SpA group was 21.4% (p=0.001).
Patients in BDSpA group
The clinical features of three patients in BDSpA group are
summarized in Table 2.
Patient 1
A 28-yr-old man presented with a painful swelling of the
right knee. This patient was previously described (11). Briefly,
he had a past history of recurrent oral ulcerations, 2 episodes
of painful scrotal ulcerations, pain on the right heel, and the
lower back pain that was worsened in the early morning and
improved with activity. Physical examination revealed mul-
tiple aphthous ulcers on the buccal mucosa, papulopustular
lesions on the anterior chest, scrotal ulcer, and inflammatory
synovitis on the right knee. The modified Schober test was
15 cm and the chest expansion was 5 cm. The pathergy reac-
tion was negative. Both HLA-B27 and B51 antigens were
positive. Bilateral SI (right: grade 4, left: grade 3) was noted
on plain pelvis radiograph and magnetic resonance imaging
(MRI) (Fig. 1). While being treated, recurrent acute iritis
with hypopyon, posterior uveitis, and papillitis in both eyes
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SPA 56 33 (58.9) 26 (46.4)
BD 58 6 (10.3)* 3 (5.2)
�
Controls 56 2 (3.6)
� 0
�
No. of 
patients
Table 1. The prevalence of sacroiliitis in BD group, SpA group
and in healthy controls
No. of patients with 
sacroiliitis (%)
No. of patients with 
definitive sacroiliitis (%)
BD, Behcet's disease; SpA, spondyloarthropathy. 
p-value between SpA group and BD group: *, <0.001; 
� , <0.001. 
p-value between BD group and healthy controls: 
� , 0.272; 
�, 0.244.
Age (yr)/sex 28/male 31/male 55/male
Orogenital ulceration + + +
Skin lesion + + -
Pathergy reaction --+
Ocular lesion +* +
� -
Inflammatory spinal pain + + -
Sacroiliitis + + -
Peripheral arthritis + - +
Enthesitis + + +
HLA-B51/B27 +/+ +/+ -/+
Patient 1 Patient 2 Patient 3
Table 2. The clinical features of patients in BDSpA group
*, Recurrent posterior uveitis; 
� , Recurrent anterior uveitis.
'were developed (Fig. 2). This case fulfilled the ISG criteria
and the modified New York criteria for AS (7).
Patient 2
A 31-yr-old man was referred to our clinic for recurrent
anterior uveitis and recurrent oral ulcerations from the oph-
thalmologic department. His past history included recurrent
oral ulcerations, 2 episodes of ulcerations on the glans penis,
three events of right anterior uveitis, pain on the left heel, left
buttock, and lower back. The lower back pain was more pro-
minent in the early morning and was relieved with exercise.
He denied any history of conjunctivitis, urethritis, psoriasis,
or a severe bout of diarrhea. Physical examination revealed
aphthous ulcerations on the tongue and multiple papulopus-
tular lesions on the back. The modified Schober test was 14.5
cm and the chest expansion was 3 cm. The pathergy reaction
was negative. HLA-B27 and HLA-B51 were positive. The
plain radiograph and MRI of pelvis revealed bilateral grade
2 SI. During the follow-up, one episode of small ulceration
on the glans penis occurred, which was not painful and healed
without scarring lesion. He concurrently satisfied the ISG
criteria and the modified New York criteria.
Patient 3
A 55-yr-old man presented with pain and stiffness of hip
girdle and lower back, diarrhea, and pain on the right lower
abdomen. His medical history disclosed recurrent oral ulcer-
ations and 2 episodes of scrotal ulcerations. Physical exami-
nation showed tenderness of the right lower abdomen, inflam-
matory synovitis of the right knee, and two scarring lesions
on the scrotum. Pain was elicited on pressure over the iliac
crests, right heel, and lower lumbar spinous processes. The
pathergy reaction was positive. HLA-B51 antigen was neg-
ative, and HLA-B27 antigen was positive. There were no
abnormal findings in the plain pelvic radiograph. Bone scan
and single photon emission computed tomography (SPECT)
showed an arthritic change on the right knee as well as an
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Fig. 1. T2-weighted magnetic resonance imaging shows an in-
creased signal intensity of subchondral marrow, and an obliter-
ation of joint space in both sacroiliac joints (right>left).
Fig. 2. Fluorescein angiogram of the right eye reveals a promi-
nent leaking of optic disc and diffuse hyperfluorescence due to
posterior vitritis.
Fig. 3. Increased uptake on the spinous processes of lower lum-
bar spines is seen on the posterior image of bone scan.increased activity on the both laminae and spinous processes
around the 4th and 5th lumbar vertebrae consistent with
enthesitis (Fig. 3 and Fig. 4). However, the sacroiliac joints
were intact on the bone SPECT. Colonoscopy revealed mul-
tiple ulcerations on the terminal ileum and ascending colon.
During the follow-up, he underwent a segmental resection
of the small intestine due to bleeding and perforation on the
ulceration of the terminal ileum. This case fulfilled the ISG
criteria and the ESSG criteria.
DISCUSSION
Moll et al. suggested that BD could be one of the SpA com-
plex on the basis of the following criteria: negative tests for
rheumatoid factor, absence of subcutaneous ( “rheumatoid")
nodules, inflammatory peripheral arthritis, radiological SI
with or without classical AS, evidence of clinical overlap be-
tween members of the group, and tendency to familial aggre-
gation (1). On the other hand, the clinical spectrum of SpA
has been recently expanded and has included the clinical dis-
orders without any involvement of the axial skeleton. In addi-
tion to AS, a prototype of SpA, reactive arthritis (including
Reiter's syndrome), arthritis associated with chronic inflam-
matory bowel disease, psoriatic arthritis, undifferentiated SpA,
and a subgroup of juvenile chronic arthritis have been com-
prised in the SpA complex (1, 6, 12). However, the inclusion
of BD into this disease entity is still debatable.
Some investigators have reported a high prevalence of AS
or SI in patients with BD (13-15). In addition, several patients
with coexisting AS and BD have been described in the liter-
ature (11, 16-19). However, other authors have found that
the prevalence of AS or SI in BD has not been different from
that in the general population (20-24). Although Dilsen et
al. reported the highest level of 33 (10%) patients with AS
and 112 (34%) with SI among 334 Turkish patients with
BD (13), other authors found no evidence of an increased
frequency of SI in patients with BD and described only one
patient with definitive AS among 114 patients with BD in
the same population (20).
Yazici et al. pointed out that the inter-observer variation
might be a major cause of discrepancies in interpreting AP
pelvis radiographs for SI (2). On the other hand, Olivieri et
al. suggested that computed tomography could reduce errors
in the radiological evaluation of the sacroiliac joint (4). There
could be no difficulty in interpreting SI in patients with mod-
erate or advanced SI. Major problem existed in minimal SI
or lower grades of SI (2, 21). The current study showed that
the frequency of SI in BD group was slightly increased with-
out statistical significance when compared to healthy con-
trols. Because of the possibility of observer's variation in read-
ing plain pelvis radiographs, we took the definitive SI into
account in our study groups. Definitive SI was not encoun-
tered in healthy controls, and it was found in 3 of BD group
(2 patients with unilateral SI and one patient with bilateral
SI). 
Besides the patients with coexisting BD and AS, cases that
concurrently met the criteria for BD and SPA without AS
have been reported (25-27). Of interest, a patient with BD
and undifferentiated SpA who had evolved into psoriatic ar-
thritis after 3 yr of the disease was described (25). A patient
affected by BD without SI or AS but with peripheral enthe-
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Fig. 4. Transverse (A) and coronal SPECT (B) slices through lower lumbar spines and pelvis show intense tracer uptake on the both lami-
nae and spinous processes of L4 and L5.
A Bsitis typical of SpA was reported (27), who resembles our pa-
tient 3 with the exception of enthesitis involving the struc-
tures around the axial skeleton. BD patients with enthesitis
involving the axial skeleton have not been described to our
knowledge. The enthesitis associated with BD has rarely been
found in the literature (14, 23). Only two patients in our BD
group had enthesitis, in whom one patient had right Achilles
tendinitis and the other had enthesitis on the right tibial tu-
berosity.
The course of eye involvement is known to be different be-
tween BD and AS. The HLA-B27-associated uveitis in SpA
mostly involves the anterior uveal tract and relatively follows
a benign course. However, the uveitis in BD usually involves
both anterior and posterior uveal tracts, and causes the loss
of sight in 25% of patients (28-30). As shown previously, the
patterns of eye involvement in BD group and SpA group of
our study were different. The eye involvement in BD group
was mostly on the posterior uveal tract, and that in SpA group
was totally on the anterior uveal tract. We experienced a 46-
yr-old female with BD who developed a nodular scleritis (31).
The diseases in SpA complex share several common fea-
tures, of which one of the most salient is the association with
HLA-B27 antigen. So far, there have been conflicting results
for the prevalence of HLA-B27 in patients with BD. Cham-
berlain found that the overall frequency of HLA-B27 in BD
patients was significantly increased, and that the level was
similar to that found in psoriasis (24). Lehner et al. described
an increased incidence of HLA-B27 in BD patients with
arthritis (32). On the other hand, others reported no associa-
tion with this antigen in BD (14). The prevalence of HLA-
B27 in the general population has shown a considerable geo-
graphic variation, and that in healthy Koreans in one study
was 5.7% (33). In this study, we could not find any BD pa-
tient with HLA-B27 antigen with an exception of patients
who concurrently fulfilled the criteria for AS or SpA. HLA-
B51 antigen has been well-known genetic factor associated
with BD. The prevalence of this antigen in BD appears to be
higher in countries adjacent to the ancient silk road includ-
ing Korea (10, 34, 35). In the present series, the frequency
of HLA-B51 in BD group was significantly higher than that
in SpA group. Because BD seems to be associated with HLA-
B51 rather than HLA-B27, this finding strongly argues ag-
ainst the hypothesis that BD could be a part of SpA complex.
Patient 1 had clinical manifestations consistent with BD
and AS. Both the HLA-B51 and B27 antigens were report-
ed to be more frequent in patients with coexisting BD and
AS (13), and in line with this, Patient 1 had both HLA-B51
and B27 antigens. This patient was considered to have actu-
ally concurrent BD and AS. Patient 2 was initially diagnosed
as BD. However, due to the presence of bilateral SI, the pa-
tient was reevaluated. He had a past history consistent with
inflammatory spinal pain and enthesitis. His recurrent uveitis
mainly involved the anterior uveal tract. The genital ulcera-
tion that developed during the follow-up was a painless small
ulceration on the glans penis, and healed without scar forma-
tion, which was clinically different from the genital ulcera-
tions of BD. We thought the clinical features of Patient 2
were closer to AS, although he had both HLA-B51 and B27.
Patient 3 had several manifestations typical of BD, except
enthesitis, and was considered to have rather BD than SpA.
To date, there have been no specific tools to diagnose the BD
or SpA, and the diagnosis mainly depends on the clinical
features and an experienced physician's judgement.
In summary, there was no patient with HLA-B27 in BD
group. SI or enthesitis was found in a minor portion of pa-
tients in BD group. In addition, the patterns of eye involve-
ment in BD group were different from those in SpA group.
We share the view with some authors that BD is not a part
of SpA complex (3, 36). However, it still remains unclear why
there have been many patients with coexisting BD and AS
or SpA, including our cases. On the other hand, in the cases that
have a SI among patients with BD, more thorough reevaluation
will be necessary.
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